With several AAV-based gene therapies now approved for use by the FDA and over 5,000 thousand patients dosed worldwide, the field of gene therapy is rapidly maturing. Learn more about how gene therapy works and the safety, tolerability and efficacy factors that are key to Tenaya’s approach.

About Gene Therapy

Gene therapy for the heart
Gene therapy's mechanism
Delivering gene therapy: focus on capsids
Safety in AAV gene therapy
Future possibilities

Contact us

Interested in connecting with Tenaya’s Medical Affairs team?

MedAffairs@Tenayathera.com